EUVIMEDEUVIMED entdecken
Crossref

AI-Based Pharmacovigilance: A Critical Review of Signal Validity

Isabella Garcia, Diego Herrera

Pharmacophore · 2026 · 17 (3) · 33-43

DOI: 10.51847/2yq2zv2ejw ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacophore, 2026. Verfasst von Isabella Garcia und 1 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) is increasingly advocated as a solution to the growing volume, complexity, and heterogeneity of pharmacovigilance data, given its ability to process spontaneous reports, electronic health records, narratives, and digital media, which has transformed expectations for drug safety surveillance. Yet, questions remain about whether AI-generated safety signals are valid, unbiased, causally meaningful, and acceptable for regulatory decision-making. This critical review eval

Zitieren

APA

Garcia, I., & Herrera, D. (2026). AI-Based Pharmacovigilance: A Critical Review of Signal Validity. Pharmacophore, 17(3), 33-43. https://doi.org/10.51847/2yq2zv2ejw

Vancouver

Garcia I, Herrera D. AI-Based Pharmacovigilance: A Critical Review of Signal Validity. Pharmacophore. 2026;17(3):33-43. doi:10.51847/2yq2zv2ejw

BibTeX
@article{Garcia2026,
  author = {Garcia, Isabella and Herrera, Diego},
  title = {AI-Based Pharmacovigilance: A Critical Review of Signal Validity},
  journal = {Pharmacophore},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {33--43},
  doi = {10.51847/2yq2zv2ejw}
}
Kostenlos starten →